Aptose Biosciences Price Patterns

APTODelisted Stock  USD 2.01  0.91  82.73%   
As of today, the value of RSI of Aptose Biosciences' share price is approaching 47. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Aptose Biosciences, making its price go up or down.

Momentum 47

 Impartial

 
Oversold
 
Overbought
The successful prediction of Aptose Biosciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Aptose Biosciences, which may create opportunities for some arbitrage if properly timed.
Using Aptose Biosciences hype-based prediction, you can estimate the value of Aptose Biosciences from the perspective of Aptose Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aptose Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Aptose because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aptose Biosciences after-hype prediction price

    
  USD 2.01  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptose Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.911.912.21
Details
Naive
Forecast
LowNextHigh
0.880.880.88
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.122.443.76
Details

Aptose Biosciences After-Hype Price Density Analysis

As far as predicting the price of Aptose Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aptose Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aptose Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aptose Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Aptose Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aptose Biosciences' historical news coverage. Aptose Biosciences' after-hype downside and upside margins for the prediction period are 2.01 and 2.01, respectively. We have considered Aptose Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.01
2.01
After-hype Price
2.01
Upside
Aptose Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Aptose Biosciences is based on 3 months time horizon.

Aptose Biosciences Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Aptose Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aptose Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aptose Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
5 Events / Month
0 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.01
2.01
0.00 
0.00  
Notes

Aptose Biosciences Hype Timeline

Aptose Biosciences is presently traded for 2.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aptose is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aptose Biosciences is about 0.0%, with the expected price after the next announcement by competition of 2.01. About 25.0% of the company shares are held by company insiders. The company recorded a loss per share of 36.38. Aptose Biosciences had not issued any dividends in recent years. The entity had 1:30 split on the 26th of February 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Aptose Biosciences Related Hype Analysis

Having access to credible news sources related to Aptose Biosciences' direct competition is more important than ever and may enhance your ability to predict Aptose Biosciences' future price movements. Getting to know how Aptose Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aptose Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GMDAGamida Cell 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
RUBYRubius Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
IDRAIdera Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NBRVFNabriva Therapeutics Plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BCELAtreca Inc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
GRTSGritstone Oncology 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ARAVAravive 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
RVLPRVL Pharmaceuticals PLC 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ONCROncorus 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
AFMDAffimed NV(0.43)3 per month 14.97  0.02  10.53 (13.54) 108.58 

Aptose Biosciences Additional Predictive Modules

Most predictive techniques to examine Aptose price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aptose using various technical indicators. When you analyze Aptose charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aptose Biosciences Predictive Indicators

The successful prediction of Aptose Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aptose Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aptose Biosciences based on analysis of Aptose Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aptose Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aptose Biosciences's related companies.

Pair Trading with Aptose Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aptose Stock

  0.78GRAB Grab HoldingsPairCorr
  0.77NIO Nio Class APairCorr

Moving against Aptose Stock

  0.88MRK Merck Company Earnings Call This WeekPairCorr
  0.87AA Alcoa CorpPairCorr
  0.81JNJ Johnson JohnsonPairCorr
  0.79DD Dupont De Nemours Sell-off TrendPairCorr
  0.77ABEV Ambev SA ADR Aggressive PushPairCorr
  0.72WMT Walmart Common StockPairCorr
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Aptose Stock

If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities